Pharmafile Logo

The healthcare market research themes for 2014

April 2, 2015 |  

As we shake off our winter coats and prepare for what will hopefully be a long, hot summer, the 2014 themes for healthcare and market research are emerging.

In the US, we have, and will continue to have, the shakedown from the implementation of the Affordable Care Act (aka Obamacare): the teething problems and the confusion, and gradually, so we hope, a clearer picture of what it means for physicians, insurers and patients – and for the industry as a whole. In the UK, we are looking at the implications of an independent Scotland following a referendum which will take place in September. For healthcare, there are some big questions – how would cross-Border healthcare work?  Would the Scottish Intercollegiate Guidelines Network (SIGN) continue to work with NICE? And in parts of Europe, particularly France, data protection laws covering market research are making some of these markets challenging to conduct studies in. Globally, the pharma industry is under increasing scrutiny to demonstrate transparent practices and legal compliance. This requirement transfers to market research suppliers such as Research Partnership, and we need to ensure we are adhering to industry guidelines and clients’ policies with regards to project management processes.

In quantitative research, we are continuing to see a trend towards respondents completing online interviews on smartphones or tablet devices. Questionnaire design and programming is starting to take this into account – it’s very difficult to complete long batteries of rating statements on a tablet simply because the selection options can be so close together. (Hitting the wrong one by accident is sometimes referred to as ‘fat-finger syndrome’!). Online or App surveys specifically designed for smartphone or tablet devices (like our ConferenceLIVE orRxRationale services), are programmed for the device so they are built with the respondent in mind.

We are also witnessing the introduction of other gamification ideas – like giving respondents a time-limit in which to answer spontaneous questions, where the aim is to understand the top-of-mind response, or using icons to replace dry number-rating scales, a range of smiling to frowning faces to indicate satisfaction or dissatisfaction or star ratings. All these tools are designed to make the whole interview experience that bit more engaging, and encourage our respondents to consider their answers.  

Beyond individual pieces of research, the role of online communities of patients or physicians and ‘scraping’ the vast wealth of pre-existing information on the internet (an example of so-called Big Data) are being explored and developed. This isn’t just about counting the number of hits or searches but about identifying and analysing relevant communications and conversations in order to gain insight into the language being used, the information needs as well as resulting behaviour.  

In qualitative research, observation techniques continue to be a trend. As a society, we are becoming more open than ever to sharing information about our daily lives. Qualitative research can benefit from this by using digital, video and face-to-face techniques to garner “uncontaminated” insights from respondents, without the intrusion of a moderator, and gain valuable information about how healthcare stakeholders interact in the real world.

Exciting times to be in healthcare market research. We hold aloft our cooling glass of Pimms and look forward to the summer ahead!

Research Partnership is one of the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical industry, we use our expertise and experience to deliver intelligent, tailor-made solutions. We provide strategic recommendations that go beyond research, helping our clients to answer their fundamental business challenges. Find out more here: http://bit.ly/1K6nhJ3

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Research Partnership launches new patient Living With Non-alcoholic Steatohepatitis (NASH) report

Living with Non-alcoholic Steatohepatitis (NASH) is a study conducted amongst 100 adults with NASH in the US. The study employs a mixed quantitative/qualitative methodology and will be available to purchase...

EULAR Annual European Congress of Rheumatology 2017

Join us at EULAR Congress 2017 in Madrid, 14-17 June

20 questions: Round 2

As it's our 20th year anniversary, we invited our employees to play our version of 20 questions - this month "What do you love about your job?"Watch the video: http://bit.ly/2qA1oP9

Taking an integrated approach to research

Director Melinda Shorr and Associate Director Steven Helm discuss the benefits of integrated research techniques.Watch the video: http://bit.ly/2qF0qO2

Online Community Research

What to consider when running an online research community?

Research Partnership appoints Helen Parfitt as Director, Head of Therapy Watch

Helen Parfitt has joined Research Partnership as Head of Therapy Watch at the company’s global head office in London. Therapy Watch is a ‘real-time’ syndicated global market tracking tool that...

Research Partnership is expanding its US capabilities with new offices opening in San Francisco and New York

Research Partnership is today expanding its US operations across both the West and East Coast. Director Tom Winter has relocated from London and is today opening a new office in...

A safe place to talk about Crohn’s

Published in eyeforpharma April 2017 by Mariel Metcalfe

Patient Assistance Programme Evaluation for Cardiovascular Conditions

Our client had launched a self-injection treatment for cardiovascular conditions and were creating an accompanying Patient Assistance Programme (PAP) to educate patients in the use and uptake of this product.Read the case...

What next for the treatment of Psoriasis in Europe?

Research Director Laurent Chanroux investigates the changing market dynamics in Psoriasis in Europe.